AREVA congratulates AmerenUE on license application for potential new reactor in Missouri
July 28, 2008
July 28, 2008
AREVA congratulates AmerenUE on the submission of a Combined License Application (COLA) for a potential new nuclear power plant to the U.S. Nuclear Regulatory Commission (NRC).
The COLA seeks regulatory approvals to potentially build a new 1,600-megawatt pressurized water reactor adjacent to AmerenUE’s existing nuclear unit, Callaway Plant, located 10 miles from Fulton, Mo.
The COLA is the second to reference AREVA’s U.S. Evolutionary Power Reactor (EPR). UniStar Nuclear Energy was the first to reference the U.S. EPR in its application for a potential new plant at Calvert Cliffs in southern Maryland.
“With the U.S. EPR design certification application in review by the NRC and two U.S. EPR COLA references, we continue on the path of certainty toward commercial operation of the first U.S. EPR,” said Ray Ganthner, AREVA NP Inc. Senior Vice President.
The EPR is the first Generation III+ reactor design being built to answer the world’s growing demand for clean and reliable electricity generation. Four EPRs are being built today including one in Finland (2011 completion), one in France (2012 completion), and two in China (2013/14 completion). The EPR has begun the prelicensing phase in the United Kingdom.
AREVA’s U.S. EPR is the first advanced reactor design or certification application that is entirely commercially funded and supported. AREVA demonstrated its confidence in nuclear energy and the U.S. market by investing more than $200 million to launch the U.S. EPR. Environmental benefits were an important objective of the EPR design and include optimizing the amount of land required for a plant of its electrical output, more efficient nuclear fuel consumption and other innovative features.
The AREVA EPR is an evolutionary 1,600+ MW net electrical output pressurized water reactor design based on proven technology. The EPR incorporates significant improvements in safety and economics over previous technologies, operating at a lower cost over the expected life of the plant and providing unparalleled safety margins for the 21st century.